Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Tuesday, May 13, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Japan Approves Sarepta’s Gene Therapy ELEVIDYS for Duchenne Muscular Dystrophy
Life Sciences Times
-
May 13, 2025
Pharma
Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD
Life Sciences Times
-
May 12, 2025
Pharma
Pioneer Institute Tool Finds Drug Price Controls Raising Costs for Many Medicare Patients
Life Sciences Times
-
May 12, 2025
Pharma
What’s a fair price for a drug that’s never developed?
Life Sciences Times
-
May 9, 2025
Pharma
AstraZeneca’s IMFINZI Shows Significant Benefit in Early Bladder Cancer, Phase III Trial Finds
Life Sciences Times
-
May 9, 2025
Pharma
ULTOMIRIS® (ravulizumab-cwvz) demonstrated sustained improvements in functional activities and quality of life in adults with generalized myasthenia gravis through 60 weeks
Life Sciences Times
-
April 6, 2022
0
Pharma
Aizon Partners with TetraScience to Help Pharmaceutical Customers Increase the Speed and Efficiency of Drug Manufacturing
Life Sciences Times
-
April 6, 2022
0
Pharma
Micreos Pharmaceuticals Welcomes Trine Ahlgreen and Carsten Edwards to Its Executive Team to Accelerate Its Next Phase of Development
Life Sciences Times
-
April 5, 2022
0
Pharma
NewAmsterdam Pharma Doses First Patient in Phase 2 Trial of Obicetrapib in Combination with Ezetimibe as an Adjunct to High-Intensity Statin Therapy
Life Sciences Times
-
April 5, 2022
0
Pharma
Alnylam Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran
Life Sciences Times
-
April 4, 2022
0
Pharma
Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package
Life Sciences Times
-
April 4, 2022
0
Pharma
ReAlta Life Sciences’ RLS-0071 Demonstrates Excellent Safety Profile and Confirmed Target Engagement in First-in-Human Phase 1 Clinical Trial
Life Sciences Times
-
April 4, 2022
0
Pharma
Cenobamate (ONTOZRY®), for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults, Is Now Available in the Netherlands
Life Sciences Times
-
April 1, 2022
0
Pharma
FDA Clears ReAlta Life Science’s Phase 2 STAR Trial of RLS-0071 in Neonates with Hypoxic-Ischemic Encephalopathy
Life Sciences Times
-
March 30, 2022
0
Pharma
Prestige Biopharma Enters MOU with Vaxine for Supply of COVID-19 Vaccine and Co-development of COVID-19/Influenza Combo Vaccine
Life Sciences Times
-
March 29, 2022
0
Pharma
FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment
Life Sciences Times
-
March 29, 2022
0
Pharma
Mercator: Data Shows Netherlands Best Base for International Pharmaceutical Companies
Life Sciences Times
-
March 29, 2022
0
1
...
29
30
31
...
64
Page 30 of 64
Most Read
K Health’s AI Physician Mode Joins Mayo Clinic Platform to Boost Primary Care Efficiency
May 13, 2025
FDA Approves GE HealthCare’s Optison for Pediatric Use, Expanding Access to Enhanced Heart Imaging
May 13, 2025
Vicarious Surgical Partners with UMass Memorial Medical Center to Advance Robotic Surgery Integration
May 13, 2025
Freespira Gains FDA Clearance for At-Home Anxiety and PTSD Treatment for Adolescents
May 13, 2025